A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD

References

• De BackerLAVosWDe BackerJvan HolsbekeCVinchurkarSDe BackerWThe acute effect of budesonide/formoterol in COPD: a multi-slice computed tomography and lung function studyEur Respir J201240229830522183484
   PubMed Web of Science ®Google Scholar
• De BackerLAVosWGSalgadoRFunctional imaging using computer methods to compare the effect of salbutamol and ipratropium bromide in patient-specific airway models of COPDInt J Chron Obstruct Pulmon Dis2011663764622162649
   PubMed Web of Science ®Google Scholar
• De BackerJVosWVinchurkarSThe effects of extrafine beclometasone/formoterol (BDP/F) on lung function, dyspnea, hyperinflation, and airway geometry in COPD patients: novel insight using functional respiratory imagingJ Aerosol Med Pulm Drug Deliv2015282889925004168
   PubMed Web of Science ®Google Scholar
• De BackerJVosWvan HolsbekeCEffect of high-dose N-acetylcysteine on airway geometry, inflammation, and oxidative stress in COPD patientsInt J Chron Obstruct Pulmon Dis2013856957924293993
   PubMed Web of Science ®Google Scholar
• De BackerJvan HolsbekeCVosWAssessment of lung deposition and analysis of the effect of fluticasone/salmeterol hydrofluoroalkane (HFA) pressurized metered dose inhaler (pMDI) in stable persistent asthma patients using functional respiratory imagingExpert Rev Respir Med201610892793327227384
   PubMed Web of Science ®Google Scholar
• De BackerLVosWDieriksBThe effects of long-term noninvasive ventilation in hypercapnic COPD patients: a randomized controlled pilot studyInt J Chron Obstruct Pulmon Dis2011661562422135493
   PubMed Web of Science ®Google Scholar
• De BackerWVosWvan HolsbekeCThe effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patientsEur Respir J201444252752924791831
   PubMed Web of Science ®Google Scholar
• VosWHajianBDe BackerJFunctional respiratory imaging to assess the interaction between systemic roflumilast and inhaled ICS/LABA/LAMAInt J Chron Obstruct Pulmon Dis20161126327126917956
   PubMed Web of Science ®Google Scholar
• IdesKVosWDe BackerLAcute effects of intrapulmonary percussive ventilation in COPD patients assessed by using conventional outcome parameters and a novel computational fluid dynamics techniqueInt J Chron Obstruct Pulmon Dis2012766767123055715
   PubMed Web of Science ®Google Scholar
• JanssensAVosWvan HolsbekeCEstimation of post-operative forced expiratory volume by functional respiratory imagingEur Respir J201545254454625537561
   PubMed Web of Science ®Google Scholar
• AstraZeneca Pharmaceuticals LPInformation SP2017 Available from: http://www.azpicentral.com/symbicort/symbicort.pdfAccessed October 6, 2017
   Google Scholar
• MartinezFJRabeKFFergusonGTEfficacy and safety of glycopyrrolate/formoterol metered dose inhaler formulated using co-suspension delivery technology in patients with COPDChest2017151234035727916620
   PubMed Web of Science ®Google Scholar
• HananiaNATashkinDPKerwinEMLong-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary diseaseRespir Med201712610511528427541
   PubMed Web of Science ®Google Scholar
• ReisnerCGottschlichGFakihF24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPDRespir Res201718115728821260
   PubMed Web of Science ®Google Scholar
• CelliBRMacneeWATS/ERS Task ForceStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
   PubMed Web of Science ®Google Scholar
• HajianBDe BackerJVosWvan HolsbekeCClukersJDe BackerWFunctional respiratory imaging (FRI) for optimizing therapy development and patient careExpert Rev Respir Med201610219320626731531
   PubMed Web of Science ®Google Scholar
• De BackerJWVosWGVinchurkarSCValidation of computational fluid dynamics in CT-based airway models with SPECT/CTRadiology2010257385486221084417
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
   PubMed Web of Science ®Google Scholar
• CazzolaMMacneeWMartinezFJOutcomes for COPD pharmacological trials: from lung function to biomarkersEur Respir J200831241646918238951
   PubMed Web of Science ®Google Scholar
• O’DonnellDELamMWebbKASpirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1999160254254910430726
   PubMed Web of Science ®Google Scholar
• O’DonnellDEFlügeTGerkenFEffects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEur Respir J200423683284015218994
   PubMed Web of Science ®Google Scholar
• O’DonnellDEVoducNFitzpatrickMWebbKAEffect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary diseaseEur Respir J2004241869415293609
   PubMed Web of Science ®Google Scholar
• O’DonnellDEImpacting patient-centred outcomes in COPD: breathlessness and exercise toleranceEuropean Respiratory Review200615993741
   Google Scholar
• TaylorGWarrenSDwivediSGamma scintigraphic pulmonary deposition study of glycopyrronium/formoterol metered dose inhaler formulated using co-suspension delivery technologyEur J Pharm Sci201811145045729055732
   PubMed Web of Science ®Google Scholar
• WatzHTroostersTBeehKMACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPDInt J Chron Obstruct Pulmon Dis2017122545255828883722
   PubMed Web of Science ®Google Scholar
• BeehKMWestermanJKirstenAMThe 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary diseasePulm Pharmacol Ther201532535925956072
   PubMed Web of Science ®Google Scholar
• DotyASchroederJVangKDrug delivery from an innovative LAMA/LABA co-suspension delivery technology fixed-dose combination MDI: evidence of consistency, robustness, and reliabilityAAPS PharmSciTech201819283784429019170
   PubMed Web of Science ®Google Scholar
• BattistiWPWagerEBaltzerLGood publication practice for communicating company-sponsored medical research: GPP3Ann Intern Med2015163646146426259067
   PubMed Web of Science ®Google Scholar